Revanesse Injection
By Revanesse
Rx
1ml Injection in a Vial

Composition
Hyaluronic Acid(NA)

Manufacturer - Ajanta Pharma Ltd
Ajanta House, Charkop, Kandivli West, Mumbai 400 067, India

Expires on or after
October, 2025

liver
Revanesse Injection appears to be safe for individuals with liver disease based on the limited data available. It is believed that adjusting the dose of Revanesse Injection may not be necessary for these patients. However, it is crucial to seek advice from your doctor regarding its use to ensure your safety and well-being.

kidney
Revanesse Injection is likely safe for patients with kidney disease. Existing data indicates no need for dose adjustment. Consult your doctor for guidance.

alcohol
When using Revanesse Injection, it is safe to consume alcohol as it does not result in any negative effects.

driving
It is uncertain if Revanesse Injection affects driving ability. Avoid driving if you have symptoms that impair concentration and reaction time.

pregnancy
Revanesse Injection may not be safe to use during pregnancy. Animal studies indicate potential harm to the developing baby. Your doctor will assess the risks versus benefits before prescribing. Consult your doctor for advice.

breastfeeding
Information on the safety of using Revanesse Injection while breastfeeding is not available. It is advised to consult your doctor before considering this treatment.
Habit Forming | No |
Chemical Class | Acylaminosugar |
Therapeutic Class | PAIN ANALGESICS |
Action Class | Osteoarthritis- Hyaluronic acid |
₹12500
Inclusive of all taxes
Content verified by

Dr. Monie Riju Simon
MBBS - General Medicine
Last update on 11-Feb-2025